Evidence map›Paper›PMID 42307079›Full record

ArticleCurrent protocols2026

Standardized Pipeline for Metabolism and Cognition in GO-DS21 Mouse Model: Investigating Down Syndrome Comorbidities.

Mohammed Selloum, Patricia da Silva-Buttkus, Fabrice Riet, Nathalia R V Dragano, Lillian Garrett, Hugues Jacobs, Sabine M Hölter, Nicolas Torquet, Birgit Rathkolb, Loic Lindner and 11 more

Abstract read
In one paragraph

Article in Current protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Mohammed SelloumUniversité de Strasbourg, CNRS, INSERM, PHEN-ICS, CELPHEDIA, UAR2062, US66, Illkirch Cedex, France.
Patricia da Silva-ButtkusInstitute of Experimental Genetics, German Mouse Clinic, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany.
Fabrice RietUniversité de Strasbourg, CNRS, INSERM, PHEN-ICS, CELPHEDIA, UAR2062, US66, Illkirch Cedex, France.
Nathalia R V DraganoInstitute of Experimental Genetics, German Mouse Clinic, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany.
Lillian GarrettInstitute of Experimental Genetics, German Mouse Clinic, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany.
Hugues JacobsUniversité de Strasbourg, CNRS, INSERM, PHEN-ICS, CELPHEDIA, UAR2062, US66, Illkirch Cedex, France.
Sabine M HölterInstitute of Experimental Genetics, German Mouse Clinic, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany.
Nicolas TorquetUniversité de Strasbourg, CNRS, INSERM, PHEN-ICS, CELPHEDIA, UAR2062, US66, Illkirch Cedex, France.
Birgit RathkolbInstitute of Experimental Genetics, German Mouse Clinic, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany.
Loic LindnerUniversité de Strasbourg, CNRS, INSERM, PHEN-ICS, CELPHEDIA, UAR2062, US66, Illkirch Cedex, France.
Valerie Gailus-DurnerInstitute of Experimental Genetics, German Mouse Clinic, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany.
Guillaume PavlovicUniversité de Strasbourg, CNRS, INSERM, PHEN-ICS, CELPHEDIA, UAR2062, US66, Illkirch Cedex, France.
Li ChanCentre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Johannes BeckersInstitute of Experimental Genetics, German Mouse Clinic, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany.
Benoit Petit DemoulièreUniversité de Strasbourg, CNRS, INSERM, PHEN-ICS, CELPHEDIA, UAR2062, US66, Illkirch Cedex, France.
Helmut FuchsInstitute of Experimental Genetics, German Mouse Clinic, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany.
Elodie EyUniversité de Strasbourg, CNRS, INSERM, Intitut de Génétique, Biologie Moléculaire et Cellulaire (IGBMC), UMR7104, U1258, Illkirch Cedex, France.
Tania SorgUniversité de Strasbourg, CNRS, INSERM, PHEN-ICS, CELPHEDIA, UAR2062, US66, Illkirch Cedex, France.
Martin Hrabe de AngelisInstitute of Experimental Genetics, German Mouse Clinic, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany.
Yann HeraultUniversité de Strasbourg, CNRS, INSERM, PHEN-ICS, CELPHEDIA, UAR2062, US66, Illkirch Cedex, France.
GO‐DS21 ConsortiumUniversité de Strasbourg, CNRS, INSERM, PHEN-ICS, CELPHEDIA, UAR2062, US66, Illkirch Cedex, France.

Funding

EUR IMCBio ANR-17-EURE-0023European Union's Horizon 2020 research and innovation program 848077German Center for Diabetes ResearchGerman Federal Ministry of Education and Research 01KX1012INBS PHENOMIN ANR-10-INBS-07Interdisciplinary Thematic Institute IMCBioSFRI-STRAT'US ANR 20-SFRI-0012University of Strasbourg, CNRS and Inserm, Agence Nationale de la Recherche IdEx Unistra ANR-10-IDEX-0002
6 · The paper itself

Abstract

Down syndrome (DS) is the most prevalent form of intellectual disability (ID) globally, with an incidence rate of approximately 1 in 1000 births, affecting over 5 million individuals worldwide. DS is characterized by a genetic profile that predisposes individuals to a range of medical and cognitive conditions, including ID and obesity, which place considerable demands on healthcare systems and families alike. Mouse models carrying DS-related genetic mutations offer valuable tools for investigating the pathophysiological mechanisms underlying DS-associated behavioral and metabolic alterations. These models also allow for an evaluation of the impact of both intrinsic and extrinsic environmental factors, aiding in the development of biomarkers and personalized therapies for individuals with DS. In this article, we establish a detailed and comprehensive phenotyping pipeline designed to incorporate high-resolution assessments of cognitive, metabolic, and behavioral variables. Using advanced phenotyping techniques alongside standardized protocols in DS mouse models, this approach systematically captures the variability of DS-associated traits. Our phenotyping pipeline aims to cover the pathways leading to cognitive dysfunction and metabolic imbalances in DS, paving the way for targeted intervention strategies. © 2026 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Diet challenge (chow diet vs. high-fat diet) Basic Protocol 2: Fecal or saliva microbiota analysis Basic Protocol 3: Body composition assessment by quantitative nuclear magnetic resonance Basic Protocol 4: Indirect calorimetry Basic Protocol 5: Blood collection and processing Basic Protocol 6: Oral glucose tolerance test Basic Protocol 7: Long-term monitoring of social groups Alternate Protocol 1: Analysis of short-term dyadic interactions between unfamiliar mice of the same genotype Alternate Protocol 2: Analysis of short-term dyadic interactions of mice from the tested strain with an unfamiliar C57BL/6J mouse Basic Protocol 8: Intraperitoneal insulin sensitivity test Basic Protocol 9: Y-maze spontaneous alternation test Alternate Protocol 3: Y-maze spontaneous alternation test version 2 Basic Protocol 10: Marble-burying analysis Alternate Protocol 4: Marble-burying analysis version 2 Basic Protocol 11: Object location memory/novel object recognition Alternate Protocol 5: Novel object recognition in the Y-maze apparatus Basic Protocol 12: Nest-building test Basic Protocol 13: Sucrose preference analysis Basic Protocol 14: Histopathology © 2026 by John Wiley & Sons, Inc.

Indexed as

CognitionDown SyndromeAnimalsBehavior, AnimalDiet, High-FatDisease Models, AnimalMaleMicePhenotypebehaviorcognitionhigh‐fat dietmouse phenotypingorganism levelphysiology

Identifiers

PMID42307079
PMCPMC13274330

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.